Tech Company Inital Public Offerings

Acutus Medical IPO

Acutus Medical was acquired by . Shares were listed on 8/6/2020.

Transaction Overview

Company Name
Announced On
8/6/2020
Transaction Type
IPO
Amount
$158,400,000
Proceeds Purpose
We currently intend to use the net proceeds from this offering as follows: approximately $40.0 million to support our commercial expansion, including hiring additional commercial personnel, approximately $22.0 million for the completion of all of our ongoing clinical trials, which includes our RECOVER AF PMA, PLASZMA trial, ablation catheter IDEs and DISCOVER registry, approximately $24.0 million for research and development activities, and the remainder for working capital and other general corporate purposes.

Company Information

Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
2210 Faraday Ave. 100
Carlsbad, CA 92008
USA
Email Address
Not Recorded
Overview
At Acutus Medical (Nasdaq: AFIB), our goal is simple: create superior outcomes for patients with Atrial Fibrillation (AF). We deeply understand the effects that AF has on people's lives, which is why we've pioneered a transformational treatment featuring the only real-time arrhythmia visualization system.
Profile
Acutus Medical LinkedIn Company Profile
Social Media
Acutus Medical Company Twitter Account
Company News
Acutus Medical News
Facebook
Acutus Medical on Facebook
YouTube
Acutus Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Vince Burgess
  Vince Burgess LinkedIn Profile  Vince Burgess Twitter Account  Vince Burgess News  Vince Burgess on Facebook
Chief Financial Officer
Gary Doherty
  Gary Doherty LinkedIn Profile  Gary Doherty Twitter Account  Gary Doherty News  Gary Doherty on Facebook
Chief Technical Officer
Graydon Beatty
  Graydon Beatty LinkedIn Profile  Graydon Beatty Twitter Account  Graydon Beatty News  Graydon Beatty on Facebook
VP - Operations
David Brengle
  David Brengle LinkedIn Profile  David Brengle Twitter Account  David Brengle News  David Brengle on Facebook
VP - R & D
Timothy Corvi
  Timothy Corvi LinkedIn Profile  Timothy Corvi Twitter Account  Timothy Corvi News  Timothy Corvi on Facebook
VP - Regulatory Affairs
Steve McQuillan
  Steve McQuillan LinkedIn Profile  Steve McQuillan Twitter Account  Steve McQuillan News  Steve McQuillan on Facebook
VP - Sales
Timothy Glynn
  Timothy Glynn LinkedIn Profile  Timothy Glynn Twitter Account  Timothy Glynn News  Timothy Glynn on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/6/2020: ANA Therapeutics venture capital transaction
Next: 8/6/2020: Kyber Data Science venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary